Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PolyNovo Biomaterials Pty Ltd.
With
PPD Development, LP
Department of Health and Human Services
Biomedical Advanced Research and Development Authority
This is a multi-center, single arm, traditional feasibility study to allow a preliminary assessment of the safety and effectiveness of BTM treatment. Patients with 10-70% TBSA burns will have BTM devices implanted in areas with deep partial or full thickness burns to treat at least 5% TBSA.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provides written informed consent (directly or via legal representative) prior to any clinical trial procedures being performed.
Willing to comply with all study procedures and expects to be available for the duration of the study.
Male and non-pregnant females ≥ 18 years of age and ≤ 70 years of age.
Patients with deep partial or full thickness burns (between 10% and 70% inclusive of their TBSA).
You may not be if
Has a known hypersensitivity to polyurethane or silver-containing materials.
Multiple traumas (significant traumatic injury to a solid organ in addition to skin).
Presence of a medical condition with a life expectancy of less than 12 months, such as advanced malignancy.
Presence of a medical condition that might interfere with treatment evaluation; or require a change in therapy including but not limited to, significant immune deficiency, or skin or vascular diseases in the area of the wound.
Female with known or suspected pregnancy, planned pregnancy, or lactation.
Has had exposure to any other investigational agent within the last 6 months.
Has a clinically significant psychiatric illness.
Has a condition the Investigator believes would interfere with the ability to comply with study instructions, or that might confound the interpretation of the study results or put the subject at undue risk.
